Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    An NIH-wide announcement about updated terminology for artificial intelligence appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T12:59:59.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:15:24.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:56:10.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the study details with a generic error screen. This indicates an access issue rather than a substantive content update on the page.
    Difference
    20%
    Check dated 2026-09-19T19:22:24.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Introduces a 2014 NIH grant/contract note and updates the page revision to v3.6.6, while the previous revision label v3.6.5 is removed.
    Difference
    0.1%
    Check dated 2026-08-29T20:17:48.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page now lists revision v3.6.5 in place of v3.6.4, indicating an updated version of the study documentation on the page. This reflects maintenance of the study record rather than changes to participant information.
    Difference
    0.1%
    Check dated 2026-08-08T18:20:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.